• SENSEX 81,911.01
    31.61 (+0.04%)
  • BANKNIFTY 61,518.50
    726.10 (+1.19%)
  • NSE
    1,994.50 1,994.50(%)
  • Reliance Industries
    1,342.10 1,611.20(%)
  • ICICI Bank
    1,592.20 1,616.70(%)
  • Kalyan Jewellers
    716.00 716.00(%)
  • Cupid
    389.00 389.00(%)
  • HDFC Bank
    813.90 1,017.90(%)
  • Sai Life
    1,881.05 786.15(%)
  • SBI
    1,089.00 1,234.80(%)
  • Kotak Mah. Bank
    494.00 494.00(%)
  • Page Industries
    31,752.10 29,800.00(%)
  • M & M
    3,369.00 2,743.15(%)
  • Gabriel India
    1,690.25 1,690.25(%)
  • Bharti Airtel
    2,071.35 1,726.05(%)
  • Cummins India
    4,311.70 6,142.80(%)
  • N S D L
    815.00 1,180.00(%)
  • Hind.Aeronautics
    4,738.80 3,479.20(%)
  • Avanti Feeds
    798.20 1,592.30(%)
  • Indegene
    672.00 672.00(%)
  • Lenskart Solut.
    738.30 767.40(%)
  • Hindustan Copper
    467.35 759.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sun Pharma Advanced Research Company Ltd Miscellaneous

  • Sun Pharma
  • BSE Code : 27675.0
  • ISIN : INE232I01014
212.35 2 (0.84%)
  • As on 12 Nov 2026 (EOD)

  • Today’s Low

    208.52

  • Today’s High

    214.93

  • Open

    210.40

  • Perv Close

    210.59

  • 52W Low

    108.00

  • 52W High

    289.00

Key Indicators

  • P/E(TTM)

    4.19

  • Mar.Cap (₹Cr.)

    6,891.22

  • Div & Yield %

    0.00

  • Book Value(₹)

    44.26

  • Debt-Equity Ratio

    0.84

  • AGM Date

    12-Nov-2026

  • EPS

    50.75

  • P/E Ratio

    4.19

Financials Ratios

  • Debt-Equity Ratio

    0.12

  • Mar.Cap (₹Cr.)

    6,891.22

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    32.45

  • BV (₹)

    44.30

  • Sales( ₹ in Cr.)

    1,879.17

  • NP (in Cr.)

    1,564.38

  • NP Var(%)

    553.0

  • Div%

    0.0

  • CPS (₹)

    48.50

  • EPS (₹)

    48.20

  • Traded Value (₹ in Lakhs)

    6,904.20

  • 52 Week High

    289.00

  • 52 Week Low

    108.00

  • Price BSE

    213.0

  • Price NSE

    212.00

  • Market Capital( in Cr.)

    6,904.20

  • P/C Ratio

    4.40

  • P/E Ratio

    4.40

  • Price Vs.BV

    48.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,879.17 71.77 75.55 238.78 137.25 252.96
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,879.17 71.77 75.55 238.78 137.25 252.96
Other Income 10.83 1.79 29.47 10.88 6.84 5.41
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 1,890.00 73.56 105.02 249.66 144.09 258.37
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 18.27 18.18
Power and Fuel Cost 6.26 6.33 6.14 5.75 4.62 4.60
Employee Cost 101.85 108.96 118.53 107.00 98.31 91.59
Other Manufacturing Expenses 44.97 48.01 55.37 45.51 17.06 17.93
Selling and Administration Expenses 116.50 230.99 292.27 289.71 183.33 252.17
Miscellaneous Expenses 24.09 4.75 7.03 4.87 2.41 3.48
Employee Benefit Expenses 101.85 108.96 118.53 107.00 98.31 91.59
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 293.67 399.04 479.34 452.84 324.00 387.94
Operating Profit 1,596.32 -325.48 -374.32 -203.18 -179.90 -129.57
Interest 34.12 8.91 1.66 7.63 13.33 10.65
Gross Profit 1,562.20 -334.39 -375.98 -210.81 -193.23 -140.22
Depreciation 10.07 10.83 12.13 11.77 10.16 10.92
Profit Before Tax 1,552.13 -345.22 -388.11 -222.58 -203.39 -151.14
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 1,552.13 -345.22 -388.11 -222.58 -203.40 -151.14
Extraordinary Items -12.24 0.03 0.58 -0.11 4.89 0.26
Adjusted Net Profit 1,564.37 -345.25 -388.69 -222.47 -208.29 -151.40
Adjustment below Net Profit 2.07 -0.26 0.19 1.35 1.70 1.53
P & L Balance brought forward -2,325.21 -1,979.73 -1,591.81 -1,370.58 -1,168.88 -1,019.27
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -771.00 -2,325.21 -1,979.73 -1,591.81 -1,370.58 -1,168.88
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 47.83 -10.64 -11.96 -6.86 -7.48 -5.77
Earnings Per Share(Adj)-Unit Curr 47.83 -10.64 -11.96 -6.86 -7.48 -5.77
Book Value 41.09 -6.80 3.85 15.80 -7.47 -6.42
Book Value(Adj)-Unit Curr 41.09 -6.80 3.85 15.80 -7.47 -6.42

Shareholding Pattern

  • Promoter Group

    65.67%

  • Public Share Holding

    34.33%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 137,217,968 42.28 137,216,768 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 65,440,885 20.17 65,440,885 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 10,301,320 3.17 10,301,320 3
Trusts 154,922 0.05 154,922 1
Others 0 0.00 0 0
Sub Total 213,115,095 65.67 213,113,895 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 668 0.00 668 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 650 0.00 566 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 12,154,629 3.75 12,153,429 50
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 308,876 0.10 308,776 8
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 36,307 0.01 36,307 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 12,501,130 3.85 12,499,746 70
2] Non Institution
Bodies Corporate 20,025,298 6.17 20,013,564 615
Clearing Members 1,355,762 0.42 1,355,762 68
Directors of their Relatives 108,433 0.03 108,433 4
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 9,600 0.00 9,600 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,618,367 0.81 2,608,011 2,143
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,732,268 0.84 2,732,268 2,958
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 13,378,548 4.12 13,378,548 18
Individuals holding nominal share capital up to Rs. 1 lakh 47,150,941 14.53 46,669,998 136,065
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 6,348 0.00 6,348 4
Others 11,352,389 3.50 11,352,389 4
Sub Total 98,905,363 30.48 98,402,330 141,908
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 324,521,588 100.00 324,015,971 141,992

Company Background

Sun Pharma Advanced Research Company LtdMiscellaneous

  • Sun Pharma Advanced Research Company Ltd
  • BSE Code : 27675.0
  • ISIN : INE232I01014

  • Incorporation Year

    2006

  • Registered Office

    Sun Pharma Advanced Res Centre
    Akota Road Akota, Vadodara,
    Gujarat-390020

  • Telephone

    91-265-2330815/2339257

  • FAX

    91-265-2354897

  • Chairman

    Dilip S Shanghvi

  • Managing Director

    Anil Raghavan

  • Company Secretary

    Kajal Damania

  • Auditor

    S R B C & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Sun Pharma Advanced Research Company Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
SPARC 212.75 1,890.00 1,879.17 4.22 111.09
Abbott India 26,603.60 7,217.19 6,929.05 34.20 43.78
Astrazeneca Phar 6,431.20 2,304.07 2,275.58 90.47 27.86
Glaxosmi. Pharma 2,655.30 3,932.76 3,790.20 39.45 58.17
Evonile Pharma 1,583.60 393.10 354.33 -1,389.12 15.94
Cipla 1,410.00 20,102.60 18,979.95 42.97 13.88
Bliss GVS Pharma 641.15 773.53 729.81 41.80 12.51
Amrutanjan Healt 507.50 520.13 502.55 25.61 24.16
Fermenta Biotec. 472.10 474.15 450.25 22.31 18.77
Guj. Themis Bio. 388.05 168.25 165.82 103.76 18.05
Ambalal Sarabhai 36.76 19.52 3.94 62.31 6.77